Skip to main content
Caplight Logo









RxPost

RxPost

Private
Marina del Rey, CaliforniaHealthcare & Life Scienceshttps://www.rx-post.com/

Last Round

Seed

Feb 6, 2026

Est. Valuation

$3M

Total Funding Raised

$1.33M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

RxPost is a healthtech company that provides a DSCSA-compliant digital marketplace and inventory management platform designed to help independent pharmacies buy and sell surplus medication inventory.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Vertical SaaS, Supply Chain, Compliance, Supply Chain Tracking

Business Model

B2B

Customer Profile

Marketplace Commission, Subscription SaaS

AI Layer

Application

Keywords

pharmacy marketplaceinventory managementDSCSA complianceDSCSAdrug supply chainpharmacy softwaremedication liquidationpharma supply chainvertical SaaSB2B marketplacepharmacy techsurplus inventoryinventory optimizationpharmacy waste reductionpharma tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RxPost Comparables

Compare RxPost with similar companies based on industry and business-model similarity.

RxPost comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
InStockRx
91%
MatchRX
88%
SureCost
61%

RxPost Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 6, 2026
GrantOct 14, 2025
Pre SeedJan 15, 2025
GrantNov 7, 2024
AcceleratorMar 12, 2024

RxPost Investors

Notable investors and investment history

RxPost investors
InvestorRounds
Capitalize VCPre Seed
Fabric VCPre Seed
Yonder VenturesPre Seed
Women Founders NetworkGrant
1752vcPre Seed
Slauson & Co.Pre Seed, Accelerator
BFA GlobalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 28, 2026

    Open roles increased to 10, representing 48% of headcount.

  • Aug 21, 2026

    Monthly visitors increased 213% MoM, reaching 6.8K.

RxPost Filings

Explore SEC and related filing metadata, where available.

RxPost filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RxPost's valuation, stock price, and market status.

Is RxPost a public or private company?

RxPost is a private company.

What is the current stock price of RxPost?

RxPost is a private company, so its shares have no public market price. Caplight tracks RxPost's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is RxPost worth (valuation)?

RxPost's valuation is estimated at $3.0M based on funding round data.

Can I buy RxPost stock?

RxPost shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was RxPost's last funding round?

RxPost's most recent funding round was Seed on February 6, 2026.

Who are the main investors in RxPost?

Key investors in RxPost include Slauson & Co..

Will RxPost IPO soon?

No public IPO plans have been announced for RxPost.

How can I track RxPost secondary market activity?

Caplight tracks bids, offers, and trades in RxPost's shares on secondary markets.

Firmographic Details

HeadquartersMarina del Rey, California
Employee Range22
Year Founded2021
Last FundingFeb 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?